LLY

903.99

0.11% -1.04

시간 외 거래: 902.75 -1.24 -0.14%

일라이 릴리 (LLY)

개요 뉴스 가격 이력 옵션 체인 Financials LLY 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$905.03

열려 있는:

$911.665

하루 거래량:

2.83M

Relative Volume:

0.91

시가총액:

$807.59B

수익:

$65.18B

순이익/손실:

$20.64B

주가수익비율:

40.02

EPS:

22.5894

순현금흐름:

$5.96B

1주 성능:

-5.36%

1개월 성능:

-8.61%

6개월 성능:

+10.33%

1년 성능:

+23.01%

1일 변동 폭

$898.15

$920.00

1주일 범위

$888.03

$963.94

52주 변동 폭

$623.78

$1,133.95

일라이 릴리 Stock (LLY) Company Profile

명칭

Lilly Eli Co

부문

Healthcare (1111)

산업

Drug Manufacturers - General (20)

전화

(317) 276-2000

주소

LILLY CORPORATE CTR, INDIANAPOLIS, IN

직원

50,000

트위터

@LillyPad

다음 수익 날짜

2024-10-30

최신 SEC 제출 서류

LLY's Discussions on Twitter

Compare LLY vs JNJ, ABBV, AZN, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LLY Lilly Eli Co	903.99	808.52B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	234.54	574.86B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	208.99	368.65B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	200.47	312.04B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	149.73	290.19B	54.72B	14.02B	15.32B	7.1855

일라이 릴리 Stock (LLY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-17	다운그레이드	HSBC Securities	Hold → Reduce
2026-02-25	개시	RBC Capital Mkts	Outperform
2026-02-20	개시	Barclays	Overweight
2026-01-07	재개	UBS	Buy
2025-12-16	업그레이드	Daiwa Securities	Neutral → Buy
2025-12-15	재확인	BofA Securities	Buy
2025-12-15	재확인	Goldman	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-11-10	업그레이드	Leerink Partners	Market Perform → Outperform
2025-10-20	재확인	BMO Capital Markets	Outperform
2025-10-14	업그레이드	Erste Group	Hold → Buy
2025-09-17	다운그레이드	Berenberg	Buy → Hold
2025-08-27	업그레이드	HSBC Securities	Reduce → Hold
2025-08-18	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-08-07	다운그레이드	Leerink Partners	Outperform → Market Perform
2025-06-05	다운그레이드	Erste Group	Buy → Hold
2025-04-28	다운그레이드	HSBC Securities	Buy → Reduce
2025-04-22	개시	Cantor Fitzgerald	Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-10-17	개시	Bernstein	Outperform
2024-09-13	재개	Citigroup	Buy
2024-08-12	업그레이드	Deutsche Bank	Hold → Buy
2024-02-21	다운그레이드	DZ Bank	Buy → Hold
2024-02-16	재확인	Morgan Stanley	Overweight
2023-12-21	다운그레이드	Daiwa Securities	Buy → Outperform
2023-11-09	개시	Deutsche Bank	Hold
2023-10-20	재개	UBS	Buy
2023-08-09	업그레이드	Jefferies	Hold → Buy
2023-07-26	재확인	Citigroup	Buy
2023-07-14	개시	HSBC Securities	Buy
2023-05-24	재확인	BofA Securities	Buy
2023-05-24	재확인	UBS	Buy
2023-03-13	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-03-06	개시	Jefferies	Hold
2023-02-15	다운그레이드	Societe Generale	Hold → Sell
2022-11-18	개시	Credit Suisse	Outperform
2022-09-22	업그레이드	UBS	Neutral → Buy
2022-05-23	개시	SVB Leerink	Outperform
2022-04-06	재개	Morgan Stanley	Overweight
2022-03-10	개시	Daiwa Securities	Outperform
2022-01-21	업그레이드	DZ Bank	Hold → Buy
2022-01-03	재확인	Bernstein	Mkt Perform
2021-12-17	개시	Goldman	Neutral
2021-12-16	재확인	BMO Capital Markets	Outperform
2021-12-16	재확인	BofA Securities	Buy
2021-12-09	재개	Wells Fargo	Equal Weight
2021-11-19	개시	BMO Capital Markets	Outperform
2021-10-11	업그레이드	Berenberg	Hold → Buy
2021-09-29	업그레이드	Citigroup	Neutral → Buy
2021-08-05	업그레이드	DZ Bank	Hold → Buy
2021-07-27	재개	Truist	Buy
2021-06-24	재확인	Cantor Fitzgerald	Overweight
2021-01-19	업그레이드	Mizuho	Neutral → Buy
2020-12-10	업그레이드	Wolfe Research	Peer Perform → Outperform
2020-11-10	재개	Bernstein	Mkt Perform
2020-09-29	개시	Berenberg	Hold
2020-09-03	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2020-06-16	업그레이드	Guggenheim	Neutral → Buy
2020-04-21	다운그레이드	UBS	Buy → Neutral
2020-04-09	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-02-06	개시	Mizuho	Neutral
2019-12-18	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2019-10-17	재개	BofA/Merrill	Buy
2019-05-28	개시	Goldman	Buy
2019-04-24	업그레이드	Edward Jones	Hold → Buy
2019-04-11	다운그레이드	Guggenheim	Buy → Neutral
2019-03-12	개시	JP Morgan	Overweight
2019-01-23	개시	UBS	Buy
2018-11-26	다운그레이드	Citigroup	Buy → Neutral
2018-10-31	업그레이드	Credit Suisse	Underperform → Neutral
2018-10-09	개시	Guggenheim	Buy
2018-10-01	재확인	SunTrust	Buy
2018-09-26	재개	JP Morgan	Overweight

모두보기

일라이 릴리 주식(LLY)의 최신 뉴스

02:21 AM

ATUM Names Genentech and Eli Lilly Veteran Gavin Barnard as Chief Scientific Officer - citybiz

01:38 AM

01:00 AM

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight - GlobeNewswire Inc.

01:00 AM

12:28 PM

Lilly eyes diabetes expansion for Foundayo after Phase III CV outcomes trial - FirstWord Pharma

12:28 PM

12:18 PM

US appeals court revives Teva lawsuit against Eli Lilly over migraine drug - Reuters

12:18 PM

12:02 PM

Braun administration, Eli Lilly to collaborate on nuclear power development - Indianapolis Business Journal

12:02 PM

11:44 AM

Leerink reiterates Eli Lilly stock rating on diabetes drug results - Investing.com

11:44 AM

11:20 AM

Is This $6.3 Billion Deal a Game Changer for Eli Lilly? - AOL.com

11:20 AM

Eli Lilly (LLY) Stock Rises as Foundayo Obesity Pill Cuts Heart Death Risk by Over Half - CoinCentral

11:20 AM

10:50 AM

Gov. Mike Braun Signs Nuclear Energy Letter Of Intent With Eli Lilly And Company - InkFreeNews.com

10:50 AM

10:24 AM

Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request - Pharmaceutical Executive

10:24 AM

10:21 AM

Eli Lilly Expands TuneLab With Vasa AI Tie Up For Drug Discovery - simplywall.st

10:21 AM

10:17 AM

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson - Benzinga

10:17 AM

10:02 AM

Lilly confirms date and conference call for first-quarter 2026 financial results announcement - marketscreener.com

10:02 AM

10:00 AM

Eli Lilly schedules April 30 webcast for first-quarter 2026 results - Stock Titan

10:00 AM

09:47 AM

Govenor Mike Braun signs Nuclear Energy Letter of Intent with Eli Lilly and Company - WBIW

09:47 AM

09:43 AM

Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel - Fierce Pharma

09:43 AM

Lilly says Foundayo pill lowers heart attack, stroke risk in study - Reuters

09:43 AM

09:31 AM

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Immunocore Holdings (IMCR) - The Globe and Mail

09:31 AM

09:21 AM

What Is Foundayo? Eli Lilly's New Diabetes Drug Is Drawing Fresh Retail Attention - Stocktwits

09:21 AM

09:17 AM

Governor Braun, Eli Lilly sign letter of intent to explore nuclear energy in Indiana - wevv.com

09:17 AM

09:07 AM

Lilly obesity pill shows no added heart risk in trial - MSN

09:07 AM

08:39 AM

Eli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar - Benzinga

08:39 AM

08:35 AM

Eli Lilly (LLY) Announces Positive Phase 3 Results for Foundayo in Type 2 Diabetes - GuruFocus

08:35 AM

07:47 AM

Eli Lilly Reveals Results of Late-Stage Study for Type 2 Diabetes Treatment - WSJ

07:47 AM

07:26 AM

Lilly’s new obesity pill passes heart safety test in diabetes - Yahoo

07:26 AM

07:21 AM

Lilly to seek FDA nod for obesity pill in diabetes (LLY:NYSE) - Seeking Alpha

07:21 AM

07:20 AM

Eli Lilly reports Foundayo met primary objective in Phase 3 ACHIEVE-4 study - TipRanks

07:20 AM

07:15 AM

Lobbying Update: $120,000 of ELI LILLY AND COMPANY lobbying was just disclosed - Quiver Quantitative

07:15 AM

07:07 AM

Lilly’s Foundayo meets cardiovascular safety goal in diabetes trial By Investing.com - Investing.com Canada

07:07 AM

06:59 AM

Lilly’s Foundayo Obesity Pill Matches Insulin in Heart Study - Bloomberg.com

06:59 AM

06:45 AM

Daily diabetes pill beats insulin on weight, A1C and heart safety - Stock Titan

06:45 AM

05:35 AM

Hedeker Wealth LLC Has $9.73 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

05:35 AM

Hardman Johnston Global Advisors LLC Acquires 20,752 Shares of Eli Lilly and Company $LLY - MarketBeat

05:35 AM

05:21 AM

Market Street Wealth Management Advisors LLC Has $18.14 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat

05:21 AM

Sumitomo Mitsui Trust Group Inc. Sells 102,900 Shares of Eli Lilly and Company $LLY - MarketBeat

05:21 AM

05:08 AM

Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market - The Motley Fool

05:08 AM

03:53 AM

Greenup Street Wealth Management LLC Takes Position in Eli Lilly and Company $LLY - MarketBeat

03:53 AM

03:09 AM

Eli Lilly and Company $LLY Shares Sold by Altfest L J & Co. Inc. - MarketBeat

03:09 AM

01:00 AM

Gov. Mike Braun signs nuclear energy letter with Eli Lilly - nwitimes.com

01:00 AM

Apr 15, 2026

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Apr 15, 2026

FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill - AOL.com

Apr 15, 2026

FDA asks Eli Lilly for more safety info on its new GLP-1 weight loss pill - The Independent

Apr 15, 2026

The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust - The Motley Fool

Apr 15, 2026

Eli Lilly Navigates Regulatory and Pipeline Milestones Ahead of Earnings - AD HOC NEWS

Apr 15, 2026

Selling pressure pushes Eli Lilly stock lower in today's trading - Traders Union

Apr 15, 2026

Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors - MedCity News

Apr 15, 2026

BMO reiterates Eli Lilly stock Outperform on manageable post-marketing requirements - Investing.com Australia

Apr 15, 2026

Lilly to acquire CrossBridge Bio for up to $300m - Pharmaceutical Technology

Apr 15, 2026